FibroBiologics, Inc. Common Stock (FBLG) vs Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
A side-by-side comparison of FibroBiologics, Inc. Common Stock and Shuttle Pharmaceuticals Holdings, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
FBLG
FibroBiologics, Inc. Common Stock
$1.13HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
SHPH
Shuttle Pharmaceuticals Holdings, Inc.
$4.06HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — FBLG vs SHPH
growth of $100 · dividends reinvested · last 3yFBLG -99.8% (-87.3%/yr)SHPH -99.5% (-83.2%/yr)SHPH compounded faster over this window
FBLG SHPH
FBLG vs SHPH: by the numbers
- •SHPH is the larger company ($2M vs $2M market cap).
Metrics side by side
Valuation
| Metric | FBLG | SHPH |
|---|---|---|
| P/B ratio | 0.51 | 0.12 |
Profitability
| Metric | FBLG | SHPH |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -391.26% | -53.49% |
| ROIC | -286.46% | -58.05% |
Go deeper
Dig into the metrics
FibroBiologics, Inc. Common Stock ROEShuttle Pharmaceuticals ROEFibroBiologics, Inc. Common Stock operating marginShuttle Pharmaceuticals operating marginFibroBiologics, Inc. Common Stock revenue growthShuttle Pharmaceuticals revenue growthFibroBiologics, Inc. Common Stock free cash flowShuttle Pharmaceuticals free cash flow
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.